Related Experiment Video
Updated: Jul 6, 2026

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
Published on: July 18, 2016
Intraperitoneal chemotherapy for women with ovarian cancer: nursing care and considerations
Kamala L Potter1, Jeanne Held-Warmkessel
1Lehigh Valley Hospital and Health Network, Allentown, PA, USA. klpotter@epix.net
Abstract:
Adjuvant treatment options for women with ovarian cancer following optimal surgical debulking traditionally have focused on IV taxane and/or platinum-based regimens. Combining intraperitoneal (IP) with IV therapy may offer a survival advantage over IV therapy alone in selected patients. The nursing care of women receiving IP chemotherapy involves unique assessment considerations, toxicity management, and patient teaching. Current IP chemotherapy administration guidelines are in various stages of development as the challenges of safe delivery to women with ovarian cancer undergo continued investigation.
Related Concept Videos
Peritoneal Dialysis III: Nursing Management
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Pericarditis IV: Nursing Management
Kidney Transplant III: Nursing Management
Planning Nursing Care I